We're raising our price target on Cardinal Health after another stellar quarter of profits
The drug distributor also raised its full-year earnings guidance.
Read at CNBC(opens in a new tab)
Full coverage
We're raising our price target on Cardinal Health after another stellar quarter of profits (opens CNBC in a new tab)
The drug distributor also raised its full-year earnings guidance.
